1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
BioELife Corp.

BioELife Corp.

LITH
BioELife Corp.US flagOther OTC
0.00
USD
- -
- -
941.00Market Cap
BioELife Corp.
LITH
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.06
-0.05
-0.05
-0.06
-0.08
-0.08
-0.06
-0.44
-0.04
-0.09
-0.1
-0.13
-0.18
Basic EPS, GAAP
-0.05
-0.05
-0.04
-0.05
-0.06
-0.04
-0.06
-0.03
-0.02
-0.06
-0.05
-0.03
-0.06
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.02
-0.07
-0.12
-0.19
-0.27
-0.35
-0.41
-0.82
-0.51
-0.52
-0.61
-0.71
-0.57
Book Value per Share
0.03
-0.02
-0.07
-0.13
-0.16
-0.24
-0.29
-0.33
-0.12
-0.13
-0.03
-0.12
- -
Tangible Book Value per Share
1
1
1
1
1
1
1
1
2
2
2
3
3
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
7.46
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'19
Jun'19
Sep'19
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
5
5
Market Capitalization
1
1
1

Working Capital

FRC

•

in mil. unless spec.
Mar'19
Jun'19
Sep'19
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
73.04%
59.62%
360.49%
Free Cash Flow
23.14%
41.58%
-37.16%
Net Income, GAAP
80.45%
153.89%
36.5%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
-0.03
-0.02
-0.02
- -
-0.1
2018
-0.02
0.07
0.01
- -
-0.13
2019
0.03
-0.04
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
JW Pharmaceutical Corporation (001065.KS)
INNOCAN PHARMA Corp (INNPF)
Voyageur Pharmaceuticals Ltd. (VM.V)
Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ)
OrganiGram Holdings Inc. (OGI.TO)
Canzon Israel Ltd. (CNZN-M.TA)
Business
BioELife Corp. operates within the cannabinoid sector, concentrating on CBD-based offerings. The company presents a variety of cannabinoid products, encompassing adult gummies, tinctures, including specialized options blended with chirorub, an intensive topical relief rub, as well as premium pre-rolls and flowers. Formerly recognized as US Lithium Corp., the organization adopted the BioELife Corp. designation in March of 2020. The firm was established in 2006 and is headquartered in Seal Beach, California.